MedPath

Oral B Neutra Foam

Oral B Neutra Foam

Approved
Approval ID

3312267e-a1a0-4935-9edb-5792192018e7

Product Type

HUMAN PRESCRIPTION DRUG LABEL

Effective Date

Jan 13, 2023

Manufacturers
FDA

YOUNG DENTAL MANUFACTURING CO 1, LLC

DUNS: 006309355

Products 1

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

Sodium Fluoride

Product Details

FDA regulatory identification and product classification information

FDA Identifiers
NDC Product Code0273-0348
Product Classification
G
Generic Name
Sodium Fluoride
Product Specifications
Route of AdministrationORAL
Effective DateJanuary 13, 2023
FDA Product Classification

INGREDIENTS (6)

COCAMIDOPROPYL BETAINEInactive
Code: 5OCF3O11KX
Classification: IACT
WATERInactive
Code: 059QF0KO0R
Classification: IACT
POLOXAMER 407Inactive
Code: TUF2IVW3M2
Classification: IACT
SUCRALOSEInactive
Code: 96K6UQ3ZD4
Classification: IACT
XYLITOLInactive
Code: VCQ006KQ1E
Classification: IACT
SODIUM FLUORIDEActive
Quantity: 0.5 mg in 1 g
Code: 8ZYQ1474W7
Classification: ACTIM

Drug Labeling Information

INDICATIONS & USAGE SECTION

LOINC: 34067-9Updated: 10/7/2015

Indication and Usage

A topically applied foaming solution to aid in the prevention of dental caries.

DESCRIPTION SECTION

LOINC: 34089-3Updated: 10/7/2015

Descrption

Oral-B Neutra-Foam ® is a mint flavored neutral aqueous foaming solution of 2.0% w/w sodium fluoride.

INACTIVE INGREDIENT SECTION

LOINC: 51727-6Updated: 10/7/2015

Inactives

Purified water,poloxamer 407, cocamidoprophylbetaine, xylitol, sucralose, flavors.

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

Oral B Neutra Foam - FDA Drug Approval Details